Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI108993

Induction of Allogeneic Unresponsiveness in Adult Dogs: ROLE OF NON-DLA HISTOCOMPATIBILITY VARIABLES IN CONDITIONING THE OUTCOME OF BONE MARROW, KIDNEY, AND SKIN TRANSPLANTATION IN RADIATION CHIMERAS

F. T. Rapaport, R. J. Bachvaroff, K. Watanabe, H. Hirasawa, N. Mollen, and J. W. Ferrebee

Department of Surgery, State University of New York at Stony Brook, Stony Brook, New York 11794

Division of Immunology, Duke University Medical Center, Durham, North Carolina 27706

The Mary Imogene Bassett Hospital, Cooperstown, New York 13326

Find articles by Rapaport, F. in: PubMed | Google Scholar

Department of Surgery, State University of New York at Stony Brook, Stony Brook, New York 11794

Division of Immunology, Duke University Medical Center, Durham, North Carolina 27706

The Mary Imogene Bassett Hospital, Cooperstown, New York 13326

Find articles by Bachvaroff, R. in: PubMed | Google Scholar

Department of Surgery, State University of New York at Stony Brook, Stony Brook, New York 11794

Division of Immunology, Duke University Medical Center, Durham, North Carolina 27706

The Mary Imogene Bassett Hospital, Cooperstown, New York 13326

Find articles by Watanabe, K. in: PubMed | Google Scholar

Department of Surgery, State University of New York at Stony Brook, Stony Brook, New York 11794

Division of Immunology, Duke University Medical Center, Durham, North Carolina 27706

The Mary Imogene Bassett Hospital, Cooperstown, New York 13326

Find articles by Hirasawa, H. in: PubMed | Google Scholar

Department of Surgery, State University of New York at Stony Brook, Stony Brook, New York 11794

Division of Immunology, Duke University Medical Center, Durham, North Carolina 27706

The Mary Imogene Bassett Hospital, Cooperstown, New York 13326

Find articles by Mollen, N. in: PubMed | Google Scholar

Department of Surgery, State University of New York at Stony Brook, Stony Brook, New York 11794

Division of Immunology, Duke University Medical Center, Durham, North Carolina 27706

The Mary Imogene Bassett Hospital, Cooperstown, New York 13326

Find articles by Ferrebee, J. in: PubMed | Google Scholar

Published March 1, 1978 - More info

Published in Volume 61, Issue 3 on March 1, 1978
J Clin Invest. 1978;61(3):790–800. https://doi.org/10.1172/JCI108993.
© 1978 The American Society for Clinical Investigation
Published March 1, 1978 - Version history
View PDF
Abstract

Exposure to supralethal total body irradiation and transplantation of bone marrow from a DLA- and pedigree-identical donor have regularly produced successful engraftment and the establishment of stable long-term chimerism in beagles of the Cooperstown colony. Bone marrow allografts performed in pairs of dogs bearing identical DLA haplotypes derived from different pedigree origins (i.e., different classes of the same haplotype) yielded two different results. Depending upon the particular haplotype pedigree combination used, such transplants either led to long-term chimerism or to failures of engraftment, secondary disease, and death of the recipients (i.e., pedigree-incompatible combinations).

Radiation chimeras given bone marrow from a DLA-and pedigree-identical donor were challenged within 8-12 h after marrow transplantation with a renal allograft obtained from another DLA- and pedigree-identical donor. The recipients have remained unresponsive to such renal allografts and have survived indefinitely with normal renal function. In contrast, renal allografts obtained from donors bearing the same DLA haplotypes derived from pedigree-incompatible sources were rejected within 25-50 days after transplantation. The long-term surviving recipients have also been unresponsive to skin allografts obtained from their donor of marrow and the kidney donor. Skin grafts obtained from other DLA- and pedigree-identical dogs were rejected within 13-41 days, and grafts from DLA-incompatible donors survived for 10-25 days.

These results highlight the potential importance of genetically controlled histocompatibility determinants other than DLA in conditioning allograft reactivity. The determinants uncovered in the present study appear to be linked to the DLA complex, as demonstrated by the ability of the pedigree origins of DLA haplotypes present in individual dogs to serve as an effective marker system for such non-DLA antigen(s). The results also point to the potential usefulness of the early postirradiation period for the induction of allogeneic unresponsiveness in large adult mammals.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 790
page 790
icon of scanned page 791
page 791
icon of scanned page 792
page 792
icon of scanned page 793
page 793
icon of scanned page 794
page 794
icon of scanned page 795
page 795
icon of scanned page 796
page 796
icon of scanned page 797
page 797
icon of scanned page 798
page 798
icon of scanned page 799
page 799
icon of scanned page 800
page 800
Version history
  • Version 1 (March 1, 1978): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts